SearchDictionaryMobileLogin

Min-Liang Kuo Selected Research

Interleukin-6 (Interleukin 6)

06/2007IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
06/2005A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth.
01/2005Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor.
12/2004Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways.
07/2004Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells.
07/2004Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma.
03/2003Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.
11/2002Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma.

Articles by Research Topic

Disease

9Neoplasms (Cancer)
06/2008 - 02/2002
8Carcinoma (Carcinomatosis)
10/2008 - 11/2002
4Breast Neoplasms (Breast Cancer)
10/2008 - 02/2003
4Stomach Neoplasms (Stomach Cancer)
06/2008 - 08/2005
3Anoxia (Hypoxia)
06/2008 - 01/2005
3Neoplasm Metastasis (Metastasis)
03/2006 - 03/2004
3Adenocarcinoma
10/2005 - 01/2004
2Small Cell Carcinoma
09/2006 - 02/2003
2Basal Cell Carcinoma (Rodent Ulcer)
05/2006 - 12/2004
1Neuroblastoma
02/2006
1Ovarian Neoplasms (Ovarian Cancer)
01/2005
1Colorectal Neoplasms (Colorectal Cancer)
01/2005
1Leukemia
01/2005
1Prostatic Neoplasms (Prostate Cancer)
07/2004
1Ascites
03/2004
1Edema
07/2003

Drug/Important Bio-Agent (IBA)

8Interleukin-6 (Interleukin 6)IBA
06/2007 - 11/2002
5Vascular Endothelial Growth Factor CIBA
06/2008 - 02/2003
5NF-kappa B (NF-kB)IBA
02/2006 - 02/2003
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2006 - 01/2004
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2005 - 11/2002
3Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
09/2006 - 10/2005
2resveratrolIBA
07/2007 - 01/2005
2GlucocorticoidsIBA
02/2006 - 10/2005
1Phosphotransferases (Kinase)IBA
10/2008
1Plasminogen Activators (Plasminogen Activator)IBA
06/2008
1Integrin alpha2beta1IBA
11/2007
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
07/2007
1Integrin alphaVbeta3IBA
06/2007
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
03/2006
1Cisplatin (Platino)FDA LinkGeneric
02/2006
1Biological FactorsIBA
02/2006
1Benzo(a)pyreneIBA
10/2005
1Interleukin-1alpha (Interleukin 1 alpha)IBA
10/2005
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2005
1arsenic trioxide (Trisenox)FDA Link
01/2005
1lysophosphatidic acid (MOPA)IBA
01/2005
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2004
11-Phosphatidylinositol 3-Kinase (PI 3 Kinase)IBA
12/2004
1beta-lapachoneIBA
07/2003
1Topotecan (Hycamtin)FDA Link
05/2003
1Novobiocin (Streptonivicin)FDA Link
05/2003
1Mitoxantrone (Novantrone)FDA LinkGeneric
05/2003
1Neuregulin-1 (Neuregulin 1)IBA
02/2003
1Interleukin-8 (Interleukin 8)IBA
02/2003
1CurcuminIBA
02/2002